265 related articles for article (PubMed ID: 30358439)
1. HDAC8 inhibition ameliorates pulmonary fibrosis.
Saito S; Zhuang Y; Suzuki T; Ota Y; Bateman ME; Alkhatib AL; Morris GF; Lasky JA
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L175-L186. PubMed ID: 30358439
[TBL] [Abstract][Full Text] [Related]
2. TGF-β
Guo W; Saito S; Sanchez CG; Zhuang Y; Gongora Rosero RE; Shan B; Luo F; Lasky JA
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L936-L944. PubMed ID: 28336812
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.
Guo W; Shan B; Klingsberg RC; Qin X; Lasky JA
Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L864-70. PubMed ID: 19700647
[TBL] [Abstract][Full Text] [Related]
5. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation.
Glenisson W; Castronovo V; Waltregny D
Biochim Biophys Acta; 2007 Oct; 1773(10):1572-82. PubMed ID: 17610967
[TBL] [Abstract][Full Text] [Related]
7. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
[TBL] [Abstract][Full Text] [Related]
8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
Fell S; Wang Z; Blanchard A; Nanthakumar C; Griffin M
Amino Acids; 2021 Feb; 53(2):205-217. PubMed ID: 33474654
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
11. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
[TBL] [Abstract][Full Text] [Related]
12. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
13. ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.
Zhang J; Wang H; Chen H; Li H; Xu P; Liu B; Zhang Q; Lv C; Song X
Autophagy; 2022 Nov; 18(11):2636-2655. PubMed ID: 35427207
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
Zhang X; Liu H; Hock T; Thannickal VJ; Sanders YY
Int J Mol Sci; 2013 Sep; 14(10):19605-17. PubMed ID: 24084714
[TBL] [Abstract][Full Text] [Related]
15. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation.
Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
[TBL] [Abstract][Full Text] [Related]
18. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
[TBL] [Abstract][Full Text] [Related]
19. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
Coward WR; Watts K; Feghali-Bostwick CA; Knox A; Pang L
Mol Cell Biol; 2009 Aug; 29(15):4325-39. PubMed ID: 19487460
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]